Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies

Cancer Biology and Therapy

Volumn 8, Issue 12, 2009, Pages 1095-1100

  Mato, Anthony R ^a,b   Fuchs, Barry D ^a   Heitjan, Daniel F ^a   Mick, Rosemarie ^a   Halpern, Scott D ^a   Shah, Payal D ^a   Jacobs, Samantha ^a   Olson, Erin ^a   Schuster, Stephen J ^a   Ujjani, Chaitra ^a   Chong, Elise A ^a   Loren, Alison W ^a   Miltiades, Andrea N ^b   Luger, Selina M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 16 Penn Tower ^*

Author keywords

Bacteremia; Febrile neutropenia; Hematologic malignancies; Infection; Leukemia; Lymphoma; Neutropenic fever; Sepsis; Septic shock; SIRS criteria

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SCORING SYSTEM; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA; TACHYPNEA;

EID: 68049137872     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.12.8528     Document Type: Article

References (29)

1. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in england, wales and northern ireland. Crit Care Med 2003; 31:2332-8.
2. Brun-Buisson C, Meshaka P, Pinton P, Vallet B; EPISEPSIS Study Group. EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in french intensive care units. Intensive Care Med 2004; 30:580-8.
3. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the united states from 1979 through 2000. N Engl J Med 2003; 348:1546-54.
4. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28:108-21.
5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the united states: Analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29:1303-10.
6. Danai PA, Moss M, Mannino DM, et al. The epidemiology of sepsis in patients with malignancy. Chest 2006; 129:1432-40.
7. Williams MD, Braun LA, Cooper LM, Martin GS. Hospitalized cancer patients with severe sepsis: Analysis of incidence, mortality and associated costs of care. Crit Care 2004; 8:291-8.
8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-77.
9. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709.
10. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-71.
11. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-96.
12. American college of chest Physicians/Society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
13. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 2003; 29:530-8.
14. Calandra T, Cohen J. International Sepsis Forum Definition of Infection in the ICU Consensus, Conference: the international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33:1538-48.
15. Flanders WD, Louv WC. The exposure odds ratio in nested case-control studies with competing risks. Am J Epidemiol 1986; 124:684-92.
16. Bamber D. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. J Math Psychol 1975; 12:387-415.
17. Bossink AW, Groeneveld AB, Koffeman GI, Becker A. Prediction of shock in febrile medical patients with a clinical infection. Crit Care Med 2001; 29:25-31.
18. Regazzoni CJ, Khoury M, Irrazabal C, Myburg C, Galvalisi NR, O'Flaherty M, et al. Neutropenia and the development of the systemic inflammatory response syndrome. Intensive Care Med 2003; 29:135-8.
19. Jaimes F, Garcés J, Cuervo J, Ramírez F, Ramírez J, Vargas A, et al. The systemic inflammatory response syndrome (SIRS) to identify infected patients in the emergency room. Intensive Care Med 2003; 29:1368-71.
20. Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Resp Crit Care 2003; 168:77-84.
21. Alberti C, Brun-Buisson C, Chevret S, Antonelli M, Goodman SV, Martin C, et al. Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Resp Crit Care 2005; 171:461-8.
22. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273:117-23.
23. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26:64-74.
24. Pittet D, Rangel-Frausto S, Li N, Tarara D, Costigan M, Rempe L, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995; 21:302-9.
25. Vincent JL. Dear SIRS, I'm sorry to say that I don't like you... Crit Care Med 1997; 25:372-4.
26. Giuliano KK. Continuous physiologic monitoring and the identification of sepsis: what is the evidence supporting current clinical practice? AACN Advanced Crit Care 2006; 17:215-23.
27. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-73.
28. Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000; 27:322-34.
29. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics 1984; 40:63-75.